DCA grants conditional registration for Ravida tablets
The Drug Control Authority (DCA) Malaysia has granted conditional registration for Ravida® Tablet 200 milligram (Ravidasvir Hydrochloride 200mg) at its 358th meeting held today, said Health director-general Dr Noor Hisham Abdullah.
He said Malaysia is the first country in the world to approve the use of Ravida®, which is indicated in combination with other medicinal products for the treatment...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable